Levetiracetam: Difference between revisions
From SEHK Wiki
No edit summary |
|||
| Line 62: | Line 62: | ||
*Increased in steps of 500 mg twice daily every 2-4 weeks | *Increased in steps of 500 mg twice daily every 2-4 weeks | ||
*Max. per dose 1.5 g twice daily | *Max. per dose 1.5 g twice daily | ||
|- | |||
!style="text-align: left"| Adjunctive therapy of myoclonic seizures and tonic-clonic seizures | !style="text-align: left"| Adjunctive therapy of myoclonic seizures and tonic-clonic seizures | ||
|''By mouth, or by intravenous infusion | |''By mouth, or by intravenous infusion | ||
Revision as of 22:57, 8 October 2020
Levetiracetam (中文: 左乙拉西坦)is an anticonvulsant medication used to treat epilepsy. It is taken either by mouth as an immediate or extended release formulation or by injection into a vein.
Pronunciation
Drug Names
| Generic Name 藥名 | HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Levetiracetam tablet 500mg | LEVE01 | P1S1S3 |
| Levetriacetam infusion 100mg/ml 5 ml | LEVE05 |
Mechanism of Action
Anticonvulsant medication. It inhibits presynaptic calcium channels, reducing neurotransmitter release. This is believed to impede impulse conduction across synapses.
Dosage
| Monotherapy of focal seizures | By mouth, or by intravenous infusion
ADULT and CHILD over 16 years:
| |
|---|---|---|
| Adjunctive therapy of focal seizures | By mouth
CHILD 1-5 months
CHILD 6 months – 17 years (body-weight up to 50 kg):
CHILD 12-17 years (body-weight 50 kg and above):
ADULT:
|
By intravenous infusion
CHILD 4-17 years (body-weight up to 50 kg):
CHILD 12-17 years (body-weight 50 kg and above):
ADULT:
|
| Adjunctive therapy of myoclonic seizures and tonic-clonic seizures | By mouth, or by intravenous infusion
CHILD 12-17 years (body-weight up to 50 kg):
CHILD 12-17 years (body-weight 50 kg or above):
ADULT:
|
